Illinois General Assembly - Bill Status for HB4822
Illinois General Assembly

Previous General Assemblies

 Bill Status of HB4822  101st General Assembly


House Sponsors
Rep. Tom Demmer - Norine K. Hammond

Last Action
DateChamber Action
  1/13/2021HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act

Synopsis As Introduced
Creates the Preserving Access to Affordable Drugs Act. Provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim in connection with the sale of a pharmaceutical product is presumed to have anticompetitive effects and is a violation of the Act if certain circumstances apply. Provides other requirements for patent infringement claims in connection with the sale of a pharmaceutical product. Contains provisions regarding presumptions in an action under the Act. Provides civil penalties for violating the Act. Provides that any penalty shall accrue only to the State of Illinois and shall be recovered in a civil action brought by the Attorney General against any party to an agreement that violates this Act. Requires an action to enforce a cause of action for a violation of the Act to be commenced within 4 years after the cause of action accrued. Contains other provisions.

DateChamber Action
  2/11/2020HouseFiled with the Clerk by Rep. Tom Demmer
  2/18/2020HouseFirst Reading
  2/18/2020HouseReferred to Rules Committee
  3/12/2020HouseAssigned to Prescription Drug Affordability & Accessibility Committee
  6/18/2020HouseAdded Chief Co-Sponsor Rep. Norine K. Hammond
  6/23/2020HouseRule 19(b) / Re-referred to Rules Committee
  1/13/2021HouseSession Sine Die

Back To Top